🚀 Moonshot Tracker
High-risk, high-reward deep tech and frontier equities
Last updated: March 26, 2026, 12:24 PM UTC
$27.3B
Combined Market Cap
$16.30-3.6%*
Black Widow orders to Asia-Pacific partner confirmed. Recent earnings showed record revenue with widening losses. YTD gains +112%.
$2.92~0%
Q4/FY2025 earnings released March 24. Dr. Ransi Somaratne appointed CMO. AI drug discovery platform advancing.
$15.77-15.6%**
Significant pullback from prior highs. Solid-state battery tech for aviation/EV progressing. Long-term thesis intact.
$4.78+48%
Dr. Vicki Goodman appointed CMO effective April 6, 2026. AI-driven drug discovery pipeline advancing with ongoing clinical programs.
$28.83-1.4%
Strong 1Y performance continues. US-based advanced packaging foundry benefiting from CHIPS Act and defense demand. Analyst targets $35-38.
$48.20+8.3%*
DNA synthesis platform scaling. Revenue per employee $385K strong. Expanding partnerships in biologics and data storage.
$6.95-1.4%
Beta 2.71 indicates high volatility. RAMP production timeline remains key catalyst. CEO Srinivasan Sivaram leads solid-state battery development.
$8.97-0.3%
FAA certification progressing. UAE deal signed. Military evaluation ongoing. Market cap remains highest in tracker.
$5.56+0.9%
Midnight eVTOL flight testing. United Airlines partnership active. Beta 3.19 highest volatility in tracker.
A$0.145+3.6%
Akida neural processor IP. Penny stock showing resilience. Only non-US position. 52W turnaround positive.